Introduction
============

Tangier disease is characterized by orange-colored tonsils, mild hepatosplenomegaly, and a decline in high-density lipoprotein cholesterol (HDL-C) concentrations in the blood. A mutation of the ATP-binding cassette transporter A1 (ABCA1) gene has been indicated as the gene responsible for Tangier disease^[@bib1]--[@bib4])^. ABCA1 transports cholesterol at the plasma membrane and is expressed throughout the body^[@bib5])^. In Tangier disease, it is believed that cholesterol is deposited in various tissues (vessel wall, *β* cells etc.), and we previously reported severely calcified coronary artery images by intravascular ultrasonography and impaired insulin secretion in ABCA1 deficiency^[@bib6],\ [@bib7])^.

Here, we describe a case of Tangier disease with extensive atherosclerotic lesions, accompanied by Leriche syndrome and bleeding tendency. Although atherosclerosis is a characteristic of Tangier disease, its frequency and severity are unclear. Therefore, we analyzed 56 papers (78 cases) and a review paper^[@bib8])^ (54 cases) and investigated the frequency and severity of atherosclerosis and bleeding tendency in Tangier disease.

Case Presentation
=================

A 53-year-old man was admitted to our hospital complaining of impotence, intermittent claudication, and a feeling of coldness in his lower extremities. He had a history of smoking from 17 to 52 years of age, 15 cigarettes per day (Brinkman Index: 525). The patient\'s father had type 2 diabetes. His mother had angina pectoris, type 2 diabetes, and renal insufficiency of unknown origin. His elder brother suffered a cerebral infarction at the age of 53. His younger sister died from sudden renal failure at 48 years of age.

From childhood, he often experienced nosebleeds. When he was 46 years old, he was diagnosed with effort angina. Coronary angiography revealed 75% stenosis in the right coronary artery \#2 and a stent was implanted. At 52 years old, he again had chest pain on effort. Left coronary angiography revealed 75% stenosis in the left main trunk ostium (**[Fig. 1A](#F1){ref-type="fig"}**) and moderate to severe diffuse stenosis from the ostium to the distal portion of the right coronary artery (**[Fig. 1B](#F1){ref-type="fig"}**). Because of the severe coronary artery stenosis, including the left main trunk and right coronary artery, he was scheduled for coronary artery bypass graft (CABG) surgery in our hospital. He was administrated aspirin, ethyl icosapentate, and pitavastatin. At that time, because he had profound systemic atherosclerosis, we re-evaluated the atherosclerosis risk factors. His body mass index was 23.4 kg/m^2^. Orange-colored swollen tonsils (**[Fig. 2A, B](#F2){ref-type="fig"}**), and mild hepatosplenomegaly were observed. HDL-C was 2 mg/dL and apolipoprotein A-1 (ApoA1) was undetectable. In addition, low hemoglobin and platelet counts were observed, consistent with a previous report^[@bib7])^. Mean platelet volume was indicative of larger platelets (**[Fig. 3A](#F3){ref-type="fig"}**). In addition, activated partial thromboplastin time was prolonged. Bleeding time was over 10 minutes (**[Supplemental Table 1](#T3){ref-type="table"}**). Among the risk factors for atherosclerosis, HDL-C was 2 mg/dL. The patient was diagnosed with Tangier disease. Fasting blood sugar level was 121 mg/dL, fasting insulin 5.9 µU/mL, and hemoglobin A1c (NGSP) was 4.9%. A 75 g oral glucose tolerance test was not performed.

![Coronary and aortic angiography before and after coronary artery bypass graft surgery at the age of 52\
In the left coronary artery (LCA), 75% stenosis was observed in the left main trunk ostium (A). In the right coronary artery ostium (RCA), moderate to severe diffuse stenosis was observed (B). In addition, multiple severe calcified lesion were observed in both the LCA and RCA on coronary angiography.\
Angiography of the aortic arch revealed irregular and eccentric stenosis of the brachiocephalic artery (C). This lesion was treated with stent implantation (8 × 27 mm) (D). A huge lesion was observed in the left subclavian artery (E).\
Angiography of the abdominal aorta and lower limbs showed severe stenosis in the right common iliac artery (open arrow) (F, G), whereas the right internal iliac artery was not contrasted (open arrowhead). In addition, severe stenosis was found in the left internal iliac artery (closed arrowhead). Angiography of the right lower limb revealed stenosis with dissection in the right common iliac artery (H). This lesion was treated with stent implantation (10×60 mm) (I).\
Abdominal aortic angiography, 2 years after coronary artery bypass graft surgery, when the patient was 53 years old. During angiography of the aortic arch, newly developed multiple severe stenoses were observed at the bifurcation of the common iliac artery. The arrowhead indicates the dissection of the abdominal aorta, which had not been observed 2 years previously ([Fig. 1-F](#F1){ref-type="fig"})) (J). Three-dimensional CT angiography of the coronal section showed severe stenosis with calcification at the ostium of the left renal artery and near the bifurcation of the common iliac artery (K). Three-dimensional CT angiography in the sagittal view showed multiple severe irregular stenoses of the abdominal aorta (open arrow) and dissection of the celiac artery (open arrowhead) (L).](jat-25-1076-g001){#F1}

![Photos of tonsils of the proband. The lingual tonsil (A) and pharyngeal tonsil (B) were orange-colored and swelling, which is a typical characteristic in Tangier disease](jat-25-1076-g002){#F2}

![Peripheral blood was stained by Giemsa (×1000). Both normal platelets (closed arrow) as well as abnormal giant ones (closed arrowhead) were observed. In addition, erythrocytes with numerous stomatocytes (arrowhead) were observed (A).\
Lipoprotein agarose gel electrophoresis was carried out. In this case, HDL was not observed at the arrow (B). The peak of VLDL (\*) was high, and a mid-band was observed between VLDL (\*) and LDL, suggesting accumulation of remnant. In this case, the second peak (arrow) was moved to the right, indicating accumulation of small-sized LDL (C). A putative model of ABCA1 mutation, V825I and N935T (D).](jat-25-1076-g003){#F3}

###### Clinical characteristics and Hemostasis Coagulation Tests of this case

                      Proband                  Normal range
  ------------------- ------------------ ----- ----------------------
  Height              160 cm                   
  Weight              60.0 kg                  
  BMI                 23.4 kg/m^2^             
                                               
                                               
  white blood cell    5,400 /µL                3,800∼8,500 /µL
  red blood cell      3.67 × 10^6^ /µL         4.00∼5.00 × 10^6^ µL
      Hemoglobin      12.3 g/dL          ↓     13.0∼16.80 g/dL
      Hematocrit      35.6%              ↓     38.0∼52.0%
  total cholesterol   98 mg/dL                 130∼219 mg/dL
  HDL-C               2 mg/dL            ↓↓↓   40∼70 mg/dL
  LDL-C               89 mg/dL                 61∼139 mg/dL
  triglyceride        67 mg/dL                 35∼149 mg/dL
  lipoprotein (a)     2 mg/dL                  ∼40 mg/dL
  apoprotein A-1      \< 5 mg/dL         ↓↓↓   119∼155 mg/dL
                                               
  Platelet counts     6.3 × 10^4^ /µL    ↓↓    10.0∼40.0 × ^4^ /µL
      MPV             12.9 fL            ↑     7.5∼11.0 fL
      PDW             17.8%              ↑     15.2∼17.2%
      PCT             0.081%             ↓     0.1∼0.3%
  PT                  90%                      80∼120%
  PT-INR              1.07                     0.87∼1.11
  APTT                40.8 sec           ↑     24.1∼35.3 sec
                                               
  Bleeding time       \> 10 minute       ↑↑    1.0∼5.0 minutes

Abbreviations: HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; MPV, mean platelet volume; PDW, platelet distribution width; PCT, plateletcrit.

We evaluated the patient\'s systemic condition, especially the peripheral arteries. Irregular and eccentric stenosis of the brachiocephalic artery was observed (**[Fig. 1C](#F1){ref-type="fig"}**). The lesion was treated with stent implantation (8 × 27 mm) (**[Fig. 1D](#F1){ref-type="fig"}**). In addition, severe stenosis was found in the left subclavian artery (**[Fig. 1E](#F1){ref-type="fig"}**) and was also treated with stent implantation. Angiography of the abdominal aorta and lower limbs revealed severe stenosis in the right common iliac artery (**[Fig. 1F](#F1){ref-type="fig"}**), whereas the right internal iliac artery was not contrasted (**[Fig. 1G](#F1){ref-type="fig"}**). In addition, severe stenosis was found in the left internal iliac artery (**[Fig. 1G](#F1){ref-type="fig"}**). In the right common iliac artery, stenosis with dissection was observed (**[Fig. 1H](#F1){ref-type="fig"}**) and treated with stent implantation (10 × 60 mm) (**[Fig. 1I](#F1){ref-type="fig"}**). After treating the peripheral arteries, we performed CABG (right internal thoracic artery-posterior descending branch, AV node branch, and left internal thoracic artery-left anterior descending branch \#8). At 5 days after surgery, cardiac tamponade occurred and was successfully controlled by platelet transfusion and pericardial drainage.

Six months later, the patient again suffered from effort angina. On coronary angiography, the radial artery graft between posterior descending branch \#4 and AV node branch \#4 was completely obstructed. We implanted a drug-eluting stent in the proximal right coronary artery to relieve the unprotected ischemic area.

Thirteen months later, at 53 years old, 1 year after the previous CABG, the patient was admitted to hospital complaining of impotence, intermittent claudication and a feeling of coldness in his lower extremities---a symptom of Leriche syndrome. The ankle-- brachial pressure index was 0.79 on the right and 0.66 on the left, respectively. Angiography revealed severe stenosis at the bifurcation of the common iliac artery and dissection of the abdominal aorta (**[Fig. 1J](#F1){ref-type="fig"}**). Three-dimensional computed tomography (CT) angiography showed incremental detritus stenosis with calcification at the ostium of the left renal artery and near the bifurcation of the common iliac artery (**[Fig. 1K, L](#F1){ref-type="fig"}**). The patient was diagnosed with Leriche syndrome and underwent aorta--external iliac artery bypass surgery and replacement of the abdominal aorta with a blood vessel prosthesis. Histology of tissue obtained from the abdominal aorta indicated an aggregation of foam cells (**Fig. 5A, B**). On the following day, difficulty in hemostasis was again observed after surgery. As in the previous bypass surgery, we transfused platelet and managed to achieve hemostasis. However, internal bleeding could not be controlled; he suffered from compartment syndrome and died from rhabdomyolysis of the lower extremities.

To evaluate the etiology of the progressive atherosclerosis, we performed additional analyzes. Polyacrylamide gel electrophoresis (**[Fig. 3B, C](#F3){ref-type="fig"}**) revealed a mid-band and increased peak of small dense low density lipoprotein (LDL). A mid-band suggested an increase of remnants, and small dense LDL were known as pro-atherogenic lipoproteins. However, an *α*-band (HDL) was not detected.

In terms of *ABCA1* gene mutation, this patient had compound heterozygosity for V825I and N935T. V825I has been previously reported and is located in the 6th transmembrane domains. N935T is a novel mutation, located between 6th transmembrane domain and ATP-hydrolyzing domain (**[Fig. 3D](#F3){ref-type="fig"}**).

Discussion
==========

Unfortunately, our case died from uncontrollable bleeding. On admission, we observed a prolonged bleeding time, which indicated platelet dysfunction, thrombocytopenia, and giant platelets in peripheral blood (**[Fig. 1L](#F1){ref-type="fig"}**). There is one previous study that investigated impaired platelet activation in ABCA1 deficiency^[@bib9])^; the authors concluded that impaired release of the content of dense bodies may explain the defective activation of ABCA1-deficient platelets by collagen and low concentrations of thrombin. In other hypoalphalipoproteinemic diseases such as apolipoprotein A1 deficiency and lecithin-cholesterol acyltransferase deficiency, there have been no case reports about bleeding tendency. To examine whether this conclusion might be universal among Tangier patients, we reviewed all previously published case reports. However, there was no clear report of bleeding tendency. On the other hand, we previously reported decreased expression of the Rho GTPase family, cdc42, in Tangier disease^[@bib10])^. We assumed that ABCA1 and cdc42 have intracellular colocalization^[@bib11])^. Interestingly, in a recent report of a patient with *de novo* cdc42 mutation^[@bib12])^, the patient had macrothrombocytopenia, which is completely consistent with our case (**[Fig. 3A](#F3){ref-type="fig"}**). Although the precise molecular mechanism has not been completely elucidated, we are assuming that our patient might have had impaired or dysfunctional interaction between ABCA1 and cdc42, inducing macrothrombocytopenia and bleeding tendency in addition to defective HDL-C.

Atherosclerosis is a characteristic of Tangier disease; however, its frequency and severity are unclear. Therefore, we analyzed 56 papers (78 cases) and a review paper^[@bib8])^ (54 cases) and investigated the frequency and severity of atherosclerosis and bleeding tendency in Tangier disease. From our analysis, we were not able to find any patient with such extensive atherosclerotic lesions as in our case. The literature search also revealed that angina was observed in 33 cases (24.8%) and other vascular diseases in 29 cases (21.8%) of total 133 cases of Tangier disease (**[Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}**). It has been considered that Tangier patients might have a pro-atherogenic profile, due to very low levels of HDL-C, which is actually not common. In contrast, our Tangier disease case had extensive severe atherosclerosis. Furthermore, this is the first case of Tangier disease accompanied by Leriche syndrome. Schaefer EJ *et al.* indicated that LDL-C levels were typically lower than normal in Tangier disease^[@bib13])^. This was explained by a twofold increase in LDL-C catabolism. However, it was also reported that the low levels of LDL-C in Tangier patients were rich in small dense LDL^[@bib13])^. In our case, small dense LDL was markedly elevated, and this could have been involved in the extensive atherosclerosis.

###### Clinical and laboratory features in Tangier disease

        age   gender   angina   other vascular disease   TCho   LDL-C            HDL-C            TG                      
  ----- ----- -------- -------- ------------------------ ------ ---------------- ---------------- ---------------- ------ --------------------------------
  1     24    M        \-       \-                       53     16               0                284              1961   Fredrickson DS *et al.*
  2     25    F        \-       \-                       63     30               0                351              1961   Fredrickson DS *et al.*
  3     25    F        \-       \-                       46     38               4                72               1964   Fredrickson DS *et al.*
  4     29    F        \-       \-                       89     80               6                131              1964   Fredrickson DS *et al.*
  5     72    M        \+       \+                       74     47               2                207              1965   Hoffman HN *et al.*
  6     48    M        \+       \+                       69     13               0                213              1965   Hoffman HN *et al.*
  7     37    M        \-       \-                       47                      8                332              1967   Kocen RS *et al.*
  8     25    F        \-       \-                       84     70               2                163              1967   Engel WK *et al.*
  9     33    F        \-       \-                       84     49               5                154              1967   Engel WK *et al.*
  10    40    M        \-       \-                       68                      4                122              1968   Kummer H *et al.*
  11    3     F        \-       \-                       70                      7                155              1970   Kracht J *et al.*
  12    5     M        \-       \-                                                                                 1971   Bale PM *et al.*
  13    15    F        \-       \-                       59     47               7                136              1971   Bale PM *et al.*
  14    53    F        \+       \+                       95                      9                180              1972   Lindeskog GR *et al.*
  15    62    M        \+       \+                       60                      0                230              1974   Haas LF *et al.*
  16    8     F        \-       \-                       83                      5                105              1974   Greten H *et al.*
  17    6     F        \-       \-                                                                                 1974   Stanios W *et al.*
  18    10    M        \-       \-                       57     35               2                110              1975   Fetrans VJ *et al.*
  19    7     M        \-       \-                       72     37               2                180              1975   Fetrans VJ *et al.*
  20    56    M        \-       \+                       114                     6                269              1975   Utermann G *et al.*
  21    2     F        \-       \-                       64                                       181              1976   Assman G *et al.*
  22    56    M        \-       \-                       60                      6                100              1976   Assman G *et al.*
  23    53    M        \-       \-                       51                      0                170              1976   Assman G *et al.*
  24    56    F        \-       \-                       90                      5                348              1976   Assman G *et al.*
  25    56    M        \-       \+                       42     22               0                297              1977   Brook JG *et al.*
  26    14    F        \-       \-                       59     49               0                102              1978   Herbert PN *et al.*
  27    69    F        \-       \+                       116    101              6                114              1978   Dyck PJ *et al*
  28    19    F        \-       \-                       80     39               4                214              1982   Suarez BK *et al.*
  29    20    F        \-       \-                       177    158              8                240              1982   Frith RW *et al.*
  30    26    M        \-       \-                       73     73               8                124              1982   Frith RW *et al.*
  31    19    M        \-       \-                       138    134              8                178              1982   Frith RW *et al.*
  32    29    F        \-       \-                       69                      0                145              1983   Ohtaki *et al*
  33    31    F        \-       \-                       60                      2                88               1983   Ohtaki *et al*
  34    15    M        \-       \-                                                                                 1984   Dechelotte P *et al*
  35    62    M        \+       \+                       79                      1                146              1984   Vergani CG *et al*
  36    28    F        \-       \-                       50     15               8                175              1984   Tarao K *et al*
  37    26    F        \-       \-                       39                      8                132              1984   Tarao K *et al*
  38    38    M        \-       \-                       55                      2                190              1985   Gibbels E *et al*
  39    53    M        \-       \-                       98                      2                355              1985   Pietrini V *et al*
  40    36    M        \-       \-                       52                                       233              1986   Clerc M *et al*
  41    65    M        \-       \-                       28                      1                202              1987   Pressly TA *et al*
  42    61    F        \-       \-                       106                     7                increased        1987   Schmalbruch H *et al*
  43    62    M        \-       \-                       72                      6                297              1987   Frohlich J *et al*
  44    27    M        \-       \-                       46                      0                244              1988   Bracco G *et al*
  45    55    F        \-       \+                       73                      1.5              658              1989   Reinhard W.H. *et al*
  46    50    M        \-       \-                       103                                      545              1989   Leal Luna A *et al*
  47    14    M        \-       \-                       25                      5                98               1990   Lo W.D. *et al*
  48          M        \-       \-                       23                      1                40               1990   Kunitake S.T. *et al*
  49          M        \-       \-                       30                      1                78               1990   Kunitake S.T. *et al*
  50    36    M                                          127                                      124              1990   Schmitz G *et al*
  51    28    M                                          35                                       89               1990   Schmitz G *et al*
  52    43    M        \-                                                        10                                1991   Dumon MF *et al*
  53    47    M        \+                                28                      6                232              1991   Matsuzawa Y *et al*
  54    46                                               123                     0                                 1991   Antoine JC *et al*
  55    61    F                                          109                     1                249              1993   Fazio R *et al*
  56    48    F        \+                                                        2                                 1993   Cheung MC *et al*
  57    52    F        \+       \+                       115    8.6              3                185              1994   C. Serfaty-Lacrosniere *et al*
  58    37    M        \+       \+                       58     21               1                365              1994   C. Serfaty-Lacrosniere *et al*
  59    40    M        \-       \-                       40     23               0                242              1994   C. Serfaty-Lacrosniere *et al*
  60    56    F                                          130                     2                                 1994   Frosini G *et al*
  61    29    M        \+       \-                       143                     3.87             164              1994   Burnett JR *et al*
  62    40    M        \-       \-                       46     19               0                242              1994   Barnard GF *et al*
  63    36    F                                          104                                      123              1996   No authors listed
  64    39    F                 \-                       89                      \< 10            487              1996   Mentis SW *et al*
  65    57    F                 \+                                                                                 1998   Neuman M *et al*
  66    8     F                                          88.2                    6.58             194              1998   Lachaux A *et al*
  67    1     M                                          84.4                    3.87             265              1998   Lachaux A *et al*
  68    55    M        \+                                36                      2                143              2000   Ohnishi M *et al*
  69    48    M        \+                                28                      6                232              2000   Komuro R *et al*
  70    50    F        \+       \+                       92.9   63.9             3.87             124              2001   Bertolini S *et al*
  71    48    M        \+                                96.3   56.8             5                75               2002   Ishii J *et al*
  72    20    M        \-                                61                      0                114              2002   Guo Z *et al*
  73    69    M        \-                                34                      0.8              187              2002   Guo Z *et al*
  74    57    M        \+                                22                      4                88               2002   Guo Z *et al*
  75    56    M        \+                                25                      1                112              2002   Takami H *et al*
  76    54    F        \-       \-                       108    absent           absent                            2003   Zuchner S *et al*
  77    32    F        \-       \-                       75.9                    1.94             162              2003   Kolovou GD *et al*
  78    29    M        \-       \-                       27                      3                231              2003   Grobusch MP *et al*
  79    36    M        \-       \-                       63     not detectable   not detectable                    2004   Sinha S *et al*
  80    52    M        \-       \-                       159    105              3.87             204              2004   Hovingh GK *et al*
  81    38    M        \+       \+                       89     50.3             3.87             177              2004   Hovingh GK *et al*
  82    42    F        \+                                147    108              3.87             228              2004   Albrecht C *et al*
  83    42    F        \-       \-                       66     52               4                37               2004   Guan JZ *et al*
  84    53    M                                          41                      4                                 2004   Morchen M *et al*
  85    72    F                                                                                                    2004   Herrmann WA *et al*
  86    42    F                 \+                       136    108              1.55             133              2006   Slatter TL *et al*
  87    17    M                                                                                                    2006   Cai Z *et al*
  88    24    M        \-                                33     10               1                100              2006   Espinel J *et al*
  89    65    M        \+       \+                       70     29               5.5              299              2007   Imai R *et al*
  90    15    F        \-       \-                       127                     5.79             166              2008   Theaudin M *et al*
  91    55    F                                          81                      4                384              2008   Sperti C *et al*
  92    49    M        \+       \+                       60                      0                                 2008   Schippling S *et al*
  93    57    M        \+                                78     37               5                178              2008   Bektas M *et al*
  94    35    F        \-       \-                                                                                 2009   Miyachi K *et al*
  95    31    F                                          98     87               1                66               2009   Maekawa M *et al*
  96    74    M        \-                                69                      3.55             42               2009   Koseki M *et al*
  97    44    M        \+                                64                      2.5              272              2009   Koseki M *et al*
  98    71    F        \+                                59                      6                162              2009   Koseki M *et al*
  99    54    M        \+                                35                      0                395              2009   Koseki M *et al*
  100   62    M        \+                                65.8   19.4             1.93             274.6            2009   Hooper AJ *et al*
  101   37    M        \+       \+                       58                      4                184              2009   Sampietro T *et al*
  102   40    M        \-       \-                       67                      2.32             114.3            2010   Cameron J *et al*
  103   55    F                                                 105              3                384              2010   Pichit P *et al*
  104   53    F        \+                                       141              5                138              2010   Pichit P *et al*
  105   43             \-       \-                                               1.93                              2012   Zyss J *et al*
  106   52             \-       \-                                               3.09                              2012   Zyss J *et al*
  107   39             \+       \+                                               1.16                              2012   Zyss J *et al*
  108   50    M        \-       \+                                               5.02                              2012   Zyss J *et al*
  109   22    M        \-       \-                       92     49               6                184              2012   Rader DJ *et al*
  110   76    F        \-       \-                       34.8   19.3             0.38             283              2012   Fasano T *et al*
  111   33    M        \+       \+                       108    46.4             5.41             283              2012   Fasano T *et al*
  112   6     F                                          61.8   34.8             2.32             133              2012   Fasano T *et al*
  113   32    M        \-       \-                       50.3   not available    1.16             186              2012   Fasano T *et al*
  114   0     M                                          96.7   22               5.03             133              2012   Fasano T *et al*
  115   69    F        \-       \+                       143    104              11.6             133              2012   Fasano T *et al*
  116   37    M        \-                                166    not available    5.41             1187             2012   Fasano T *et al*
  117   60    F        \-       \+                       217    139              27.8             310              2012   Fasano T *et al*
  118   54    M        \-       \+                       224    128              22               390              2012   Fasano T *et al*
  119   52    M        \-       \+                       228    155              18.9             328              2012   Fasano T *et al*
  120   45    F        \+       \+                       60     34               unmeasurable     103              2012   Pervaiz MA *et al*
  121   59    F        \+       \+                       57     31               2                                 2012   Feng W *et al*
  122   38    F        \-       \+                       124    106              \< 5             138              2013   Negi SI *et al*
  123   51    M        \-       \-                       48     8                1                not detectable   2014   Lucchi T *et al*
  124   58    F                 \+                       60                      2                448              2014   Sechi A *et al*
  125   12    M        \-       \-                       48     0                0.6              319              2014   Sahiner N *et al*
  126   3     M                                          60     41.4             \< 3.1                            2014   Ravesloot *et al*
  127   22    F                                          50     27               3.1              108              2015   Brunham LR *et al*
  128   26    M                 \-                       65     34               7.7              114              2015   Brunham LR *et al*
  129   4     F                                          49.9   14.7             5.41             151              2015   Brunham LR *et al*
  130   16    M        \-       \-                       86     49.8             \< 5             86               2015   Per H *et al*
  131   17    M        \-       \-                       59                      2                107              2016   Murano T *et al*
  132   43    M                 \-                       149    110              5                                 2016   Nagappa M *et al*

Abbreviations: The same cases were described with preference to the latest report. TCho, total cholesterol (mg/dL); LDL-C, low density lipoprotein-cholesterol (mg/dL); HDL-C, high density lipoprotein-cholesterol (mg/dL); TG, triglycerides (mg/dL).

###### Clinical characteristics and lipid profiles of Tangier patients divided by presence or absence of atherosclerosis

  male            CVD(+)              CVD(−)              *p*-value
  --------------- ------------------- ------------------- -----------
  age             51.1 ± 10.3         34.9 ± 17.7         \< 0.001
  TCho (mg/dL)    65.8 (42.0, 89.0)   58.0 (46.3, 72.0)   0.347
  LDL-C (mg/dL)   52.1 ± 44.4         46.9 ± 40.9         0.377
  HDL-C (mg/dL)   3.87 (1.00, 5.31)   2.00 (1.00, 5.00)   0.555
  TG (mg/dL)      231 (173, 286)      184 (112, 242)      0.110

  female          CVD(+)              CVD(−)              *p*-value
  --------------- ------------------- ------------------- -----------
  age             54.2 ± 9.71         28.8 ± 18.1         \< 0.001
  TCho (mg/dL)    105 (63.3, 130)     73.0 (59.8, 89.0)   0.049
  LDL-C (mg/dL)   85.9 ± 44.7         53.9 ± 37.7         0.038
  HDL-C (mg/dL)   3.87 (2.00, 6.00)   5.00 (1.97, 7.00)   0.932
  TG (mg/dL)      150 (133, 217)      159 (131, 206)      0.709

These statistical analyses were performed using the STATA version 11.0 (Stata, College Station, TX, USA) statistics software package. Data are expressed as mean ± s.d. or median (interquartile range; 25--75%) because of histogram. All participants were using *t*-tests or Wilcoxon\'s signed rank tests appropriately.

TCho, total cholesterol; LDL-C, low density lipoprotein-cholesterol; HDL-C, high density lipoprotein-cholesterol; TG, triglycerides.

Regarding the mutational analysis of *ABCA1* gene, there is a report that V825I was associated with coronary artery disease while having no effect on HDL-C or ApoA1 levels^[@bib14])^. In addition, the V825I mutation is located in the transmembrane domain^[@bib15])^. Frikke-Schmidt *et al.* genotyped single-nucleotide polymorphisms of 69,259 individuals and found that V825I affected the risk of coronary artery disease^[@bib16])^. On the other hand, Yin *et al.* suggested that there was no significant association between the V825I polymorphism and the risk of atherosclerosis^[@bib17])^. Thus, the association between V825I and cardiovascular disease is controversial. In our case, the other mutation, N935T is a novel mutation, located between 6th transmembrane domain and ATP-hydrolyzing domain. We consider that the feature of this novel mutation might be associated with transportation of cholesterol.

There still remain many unknown points regarding the pathophysiology of Tangier disease. Further investigation is required to assess the incidence and the mechanism of atherosclerosis and bleeding tendency in Tangier patients.
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